Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life (HYPOAGE)

This is an interventional other trial for Type2 Diabetes focused on measuring Type 2 Diabetes, Hypoglycemia, Elderly, Insulinotherapy Read More

Inclusion Criteria:

• Male or female ≥ 75 years of age;
• Type 2 diabetes for at least 1 year and treated with insulin for at least 6 months;
• Treated with basal insulin (ie glargine U100: Lantus®, Abasaglar®, glargine U300: Toujeo®, detemir: levemir®, NPH), premix (ie Novomix® and Humalog Mix®), and / Insulin associated or not with one or more oral and / or injectable antidiabetic agents (analog of GLP1...);
• Benefiting from at least 1 capillary glucose per day (carried out by the patient himself or a caregiver);
• Benefiting from a standardized geriatric assessment;
• Signature of informed consent
• Patient benefiting from a social security system.

Exclusion Criteria:

• Male or female aged <75 years;
• Person without diabetes or type 1 diabetes;
• Patient treated only lifestyle modifications and / or oral anti-diabetic drugs and / or GLP-1 receptor agonists alone;
• Subjects with secondary or corticosteroid-induced diabetes;
• Refusal to participate in the study or inability to collect consent;
• Patient for whom follow-up of the study procedures is impossible (glycemic record impossible or insufficient);
• Patient not eligible for geriatric assessment;
• Patient already participating in another study;
• Patient with a severe pathology limiting his life expectancy (palliative care ...) compromising his participation in the study at the discretion of the investigator;
• Patient benefiting from a safeguard of justice.